PMA device
TactiCath Quartz Contact Force Ablation Catheter
St Jude Medical · Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Fibrillation (OAE, Class III) · First FDA decision Oct 24, 2014, newest Aug 3, 2021Atrial fibrillation
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
5
PMA pathway
Device trials
2
Naming "TactiCath Quartz"
MAUDE reports
925
Brand "TactiCath Quartz", since 2015
PubMed studies
8
Mentioning "TactiCath Quartz"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing TactiCath Quartz Contact Force Ablation Catheter
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 5 of 5 decisions filed under this name.
- TactiCath Quartz Contact Force Ablation CatheterPMA supplement
P130026-S069 · Decided Aug 3, 2021 · 179 days after receipt · Normal 180 Day Track No User Fee
Device type: Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation (OAE) · Cardiology
- TactiCath Quartz Catheter and TactiSys Quartz EquipmentPMA supplement
P130026-S062 · Decided Nov 2, 2020 · 112 days after receipt · Normal 180 Day Track
Device type: Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation (OAE) · Cardiology
- TACTICATH QUARTZ SETPMA supplement
P130026-S048 · Decided Aug 22, 2019 · 59 days after receipt · Normal 180 Day Track No User Fee
Device type: Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation (OAE) · Cardiology
2 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Percutaneous Left Atrial Appendage Closure (LAAC)National determinationOn the books20.34Updated Nov 4, 2026
- Percutaneous Left Atrial Appendage (LAA) Closure TherapyNational analysisReview closedCAG-00445NUpdated Sep 21, 2026
- Cardiac Catheterization Performed In Other Than A Hospital SettingNational analysisReview closedCAG-00166NUpdated Sep 16, 2026
- Cardiac Catheterization Performed in Other than a Hospital Setting - RETIREDNational determinationOn the books20.25Updated Dec 3, 2024
- Cardiac Catheterization and Coronary AngiographyLocal determinationIn effectL33959CGS Administrators, LLCUpdated Oct 30, 2026
- Cardiac Catheterization and Coronary AngiographyLocal determinationIn effectL33557Wellpoint FederalUpdated Jul 14, 2026
- Percutaneous minimally invasive fusion/stabilization of the sacroiliac joint for the treatment of back painLocal determinationIn effectL36000WPS Insurance CorporationUpdated May 21, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "TactiCath Quartz", any status and sponsor, newest update first.
- DiamondTemp™ Ablation System for the Treatment of Paroxysmal Atrial FibrillationPivotal-lookingCompleted
Medtronic Cardiac Ablation SolutionsPublic (MDT)
NCT03334630 · 482 participants · Start Nov 6, 2017 · Primary completion Nov 18, 2019
Device: DiamondTemp Ablation catheter; TactiCath Quartz Ablation catheter · For: Paroxysmal Atrial Fibrillation; Atrial Fibrillation
Sites: Birmingham, Alabama; Los Angeles, California; Redwood City, California · 23 sites in all
- TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval StudyCompleted
Abbott Medical DevicesPublic (ABT)
NCT02310100 · 178 participants · Start Jan 21, 2015 · Primary completion Feb 2017
Device: TactiCath Quartz treatment · For: Paroxysmal Atrial Fibrillation
Sites: Glendale, California; Sacramento, California; Atlanta, Georgia · 20 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "TactiCath Quartz", and for the whole product code for context.
This brand
925 reports: 460 malfunction, 430 injury, 34 death
Whole product code OAE
11,261 reports: 5,551 malfunction, 5,370 injury, 334 death
Newest reports for this brand
3008452825-2026-00446 · Received Aug 18, 2026
Device type: Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Fibrillation (OAE)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Cardiac Perforation
3008452825-2026-00458 · Received Aug 18, 2026
Device type: Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Fibrillation (OAE)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Low Blood Pressure/ Hypotension; Cardiac Tamponade; Pericarditis
3008452825-2025-00544 · Received Oct 30, 2025
Device type: Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Fibrillation (OAE)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Nerve Damage
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- TactiFlex Ablation Sensor Enabled Ablation Catheter, Models A-TFSE-FJ, 7.5 F shaft and an 8F distal section, Sterile.Open, Classified
St. Jude Medical, Atrial Fibrillation Division, Inc.
Z-0814-2024 · Started Dec 18, 2023 · Posted by FDA Jan 25, 2024
Reason given: When the catheters are used with the EnSiteX EP System, the system does not correctly recognize the catheter as the appropriate product model and instead reads and displays it as a different model. This results in some features specific to the catheter do not appear on the display and the catheter image may also...
Cause as FDA categorized it: Under Investigation by firm · Device type: Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Fibrillation (OAE)
Z-0956-2022 · Started Mar 24, 2022
Reason given: Devices were manufactured with a "First Use Date" preprogrammed in the EEPROM which disables the use of the single-use device.
Cause as FDA categorized it: Process control · Device type: Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Fibrillation (OAE)
Z-0957-2022 · Started Mar 24, 2022
Reason given: Devices were manufactured with a "First Use Date" preprogrammed in the EEPROM which disables the use of the single-use device.
Cause as FDA categorized it: Process control · Device type: Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Fibrillation (OAE)
3 more recall records with a free account
Published research
The most relevant PubMed records for "TactiCath Quartz"[tiab]. The summary above synthesizes these.
- Validation of the accuracy of contact force measurement by contemporary force-sensing ablation catheters.
Kueffer T, Haeberlin A, Knecht S, et al. · J Cardiovasc Electrophysiol · 2023Research Support, Non-U.S. Gov't
- Contact force guided radiofrequency current application at developing myocardium.
Backhoff D, Müller MJ, Betz T, et al. · J Cardiovasc Electrophysiol · 2022Research Support, Non-U.S. Gov't
- Safety of catheter ablation of atrial fibrillation using fiber optic-based contact force sensing.
Mansour M, Lakkireddy D, Packer D, et al. · Heart Rhythm · 2017Multicenter Study, Randomized Controlled Trial
- Lesion index: a novel guide in the path of successful pulmonary vein isolation.
Dello Russo A, Fassini GM, Casella M, et al. · J Interv Card Electrophysiol · 2019
- Fiberoptic Contact-Force Sensing Electrophysiological Catheters: How Precise Is the Technology?
Bourier F, Gianni C, Dare M, et al. · J Cardiovasc Electrophysiol · 2017
- Lesion Size Index in Maximum Voltage-Guided Cavotricuspid Ablation for Atrial Flutter.
Boles U, Gul EE, Fitzpatrick N, et al. · J Innov Card Rhythm Manag · 2017
- Comparison of atrial fibrillation ablation efficacy using remote magnetic navigation vs. manual navigation with contact-force control.
Jez J, Jadczyk T, Lehar F, et al. · Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub · 2020Comparative Study
- Contact-Force Guided Pulmonary Vein Isolation does not Improve Success Rate in Persistent Atrial Fibrillation Patients and Severe Left Atrial Enlargement: A 12-month Follow-Up Study.
Gul EE, Boles U, Haseeb S, et al. · J Atr Fibrillation · 2018
Other devices of this type
Also filed under product code OAE.
- Arctic Front Advance and Arctic Front Advance ProMedtronic Cryocath, LP · PMA 2024
- Arctic Front Cardiac Cryoablation Catheter SystemMedtronic Cryocath, LP · PMA 2024
- TactiCath Contact Force Ablation Catheter, Sensor EnabledSt Jude Medical · PMA 2023
- HeartLight Catheter, HeartLight X3 Console V2Cardiofocus, Inc. · PMA 2023
- TactiFlex Sensor Enabled Ablation CatheterAbbott Medical · PMA 2026
- DiamondTemp Ablation SystemMedtronic, Inc. · PMA 2025
- QDOT MICRO SystemBiosense Webster, Inc. · PMA 2025
- POLARx/POLARx FIT Cryoablation CathetersBoston Scientific Corporation · PMA 2024
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.